Korean College of Rheumatology Biologics and Targeted Therapy Registry

NCT01965132 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2024-04-26

No results posted yet for this study

Summary

We established a nationwide biologics and targeted synthetic DMARDs registry (in the form of an inception cohort) to study the safety profiles in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis patients receiving biologics or targeted synthetic DMARDs. As this registry is to observe the "real world" use of anti-rheumatic treatments under routine clinical practice, no hypothesis to prove is planned.

Conditions

Interventions

DRUG

Biologic or targeted synthetic DMARD

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Eun Yeong Lee, MD · Seoul National University Hospital

  • Tae-Hwan Kim, MD · Hanyang University

  • Shin-Seok Lee, MD · Chonnam National University Hospital

  • Jaejoon Lee, MD · SAMSUNG MEDICL CENTER

  • Changhoon Lee, MD · Wonkwang University Hospital

  • Chang-Keun Lee, MD · Asan Medical Center

  • Hyoun-Ah Kim, MD · Ajou University School of Medicine

  • Sang-Il Lee, MD · Gyeongsang National University Hospital

  • Jung-Yoon Choe, MD · Daegu Catholic University Medical Center

  • Jae Hyun Jung, MD · Korea University Ansan Hospital

  • Mi Ryoung Seo, MD · Gachon University Gil Medical Center

  • Jinseok Kim, MD · Jeju National University Hospital

  • Mihye Kwon, MD · KONYANG UNIV. HOSPITAL

  • Joo-Hyun Lee, MD · Inje University Ilsan Paik Hospital

  • Seong Wook Kang, MD · Chungnam National University Hospital

  • Kwi Young Kang, MD · THE CATHOLIC UNIV. OF KOREA INCHEON ST. MARY'S HOSPITAL

  • Sung Won Lee, MD · Dong-A University Hospital

  • Young-Beom Park, MD · Severance Hospital

  • Hyun-Sook Kim, MD · Soonchunhyang University Hospital

  • Dae Hyun Yu, MD · Hanyang University

  • Sang-Heon Lee, MD · Konkuk University Medical Center

  • Young Mo Kang, MD · Kyungpook National University Hospital

  • Ki Won Moon, MD · KangWon National University Hospital

  • Seung-Jae Hong, MD · Kyunghee University Medical Center

  • Sang-Hyun Kim, MD · Keimyung University Dongsan Medical Center

  • Gwan Gyu Song, MD · Korea University Guro Hospital

  • Jiwon Hwang, MD · Samsung Changwon Hospital

  • Sung Hae Chang, MD · Soonchunhyang University Hospital

  • JINHYUN KIM, MD · Chungnam National University Hospital

  • Joo-Hyun Lee, MD · INJE UNIVERSITY ILSAN PAIK HOSPTIAL

  • Wan Hee Ryu, MD · Chonbuk National University Hospital

  • In-Ah Choi, MD · Chungbuk National University Hospital

  • Hyun Ah Kim, MD · HALLYM UNIVERSITY HOSPITAL

  • Kichul Shin, MD · SMG-SNU Boramae Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-01
Primary Completion
2029-12-31
Completion
2030-06-30
FDA Drug
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01965132 on ClinicalTrials.gov